Effect of deoxyribonuclease I treatment for dementia in end-stage Alzheimer’s disease: a case report

BACKGROUND: Alzheimer's disease is the most common cause of dementia and is characterized by a progressive loss of brain tissue leading to amyloid-β accumulation and severe decline in cognitive function. The cause of Alzheimer’s disease is poorly understood, and available treatments are limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Tetz, Victor, Tetz, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884412/
https://www.ncbi.nlm.nih.gov/pubmed/27234814
http://dx.doi.org/10.1186/s13256-016-0931-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884412/
https://www.ncbi.nlm.nih.gov/pubmed/27234814
http://dx.doi.org/10.1186/s13256-016-0931-6

Ejemplares similares